Fully automated analytical method for mycophenolic acid quantification in human plasma using on-line solid phase extraction and high performance liquid chromatography with diode array detection

Therapeutic Drug Monitoring

Volumn 28, Issue 4, 2006, Pages 505-511

  Daurel Receveur, Mathilde ^a,b   Titier, Karine ^a,b,c   Picard, Stéphane ^a,b   Ducint, Dominique ^a,b   Moore, Nicholas ^a,b   Molimard, Mathieu ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

ASPEC; Liquid chromatography; Mycophenolic acid; Solid phase extraction

Indexed keywords

ACEBUTOLOL; ACETYLSALICYLIC ACID; ACICLOVIR; AMOXICILLIN; AZATHIOPRINE; BROMAZEPAM; BUSPIRONE; CARBAMAZEPINE; CEFALEXIN; CEFALOTIN; CEFEPIME; CEFTRIAXONE; CHLORDIAZEPOXIDE; CHLOROPHACINONE; CIPROFLOXACIN; CITALOPRAM; CLAVULANIC ACID; CYCLOSPORIN; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; ETHOSUXIMIDE; FLECAINIDE ACETATE; FLUOXETINE; FLURBIPROFEN; MIDAZOLAM; MYCOPHENOLIC ACID; OXAZEPAM; TACROLIMUS; UNINDEXED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG RETENTION; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

EID: 33746840186     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200608000-00004     Document Type: Article

References (31)

1. Bullingham R, Nicholls A, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998;34:429-455.
2. Cox VC, Ensom MH. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmakokinetic monitoring? Ther Drug Monit. 2003;25:137-157.
3. Sintchak MD, Nimmesgern E. The structure of inosine 5′- monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 2000;47:163-184.
4. Jonsson CA, Carlsten H. Mycophenolic acid inhibits inosine 5-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells. Int Immunopharmacology. 2003;3:31-37.
5. Keogh A. Calcineurin inhibitors inheart transplantation. J Heart Lung Transplant. 2004;23:202-206.
6. Salvadori M, Holzer A, de Mattos A, et al. Enteric-coated Mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant. 2003;4:231-236.
7. van Gelder T, Hilbrands L, Vanrenterghem Y, et al. a randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation. 1999;68:261-266.
8. Hale MD, Nicholls AJ, Bullingham RE, et al. The pharmacokinetic- pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther. 1998;64:672-683.
9. Nicholls A. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetics- pharmacodynamic relationship for mycophenolic acid and suppression of rejection. Clin Biochem. 1998;31:329-333.
10. Sugioka N, Odani H, Ohta T, et al. Determination of a new immunosuppressant, mycophenolate mofetil, and its active metabolite, mycophenolic acid, in rat and human body fluids by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1994;654:249-256.
11. Na-Bangchang K, Supasyndh O, Supaporn T, et al. Simple and sensitive high-performance liquid chromatographic. J Chromatogr B Biomed Sci Appl. 2000;738:169-173.
12. Pastore A, Lo Russo A, Piemonte F, et al. Rapid determination of mycophenolic acid in plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;776:251-254.
13. Gummert JF, Christians U, Barten M, et al. High-performance liquid chromatographic assay with a simple extraction procedure for sensitive quantification of mycophenolic acid in rat and human plasma. J Chromatogr B Biomed Sci Appl. 1999;721:321-326.
14. Srivatsan V, Dasgupta AK, Kale P, et al. Determination of mycophenolic acid in human plasma by high-performance liquid chromatography. J Chromatogr A. 2004;1031:259-264.
15. Shipkova M, Niedmann PD, Armstrong VW, et al. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem. 1998;44:1481-1488.
16. Hosotsubo H, Takahara S, Kokado Y, et al. Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection. J Pharm Biomed Anal. 2001;24:555-560.
17. Indjova D, Kassabova L, Svinarov D. Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;817:327-330.
18. Streit F, Shipkova M, Armstrong VW, et al. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem. 2004;50:152-159.
19. Mandla R, Line PD, Midtvedt K, et al. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit. 2003;25:407-414.
20. Atcheson B, Taylor PJ, Mudge DW, et al. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;799:157-163.
21. Tsina I, Chu F, Hama K, et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr B Biomed Appl. 1996;675:119-129.
22. Annesley TM, Clayton LT. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin Chem. 2005;51:872-877.
23. Watson DG, Araya FG, Galloway PJ, et al. Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients. J Pharm Biomed Anal. 2004;35:87-92.
24. Zambonin CG, Aresta A, Palmisano F. Determination of the immunosuppressant mycophenolic acid in human serum by solid-phase microextraction coupled to liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;806:89-93.
25. Vogl M, Weigel G, Seebacher G, et al. Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring. Ther Drug Monit. 1999;21:638-643.
26. Brunet M, Oppenheimer F, Martorell J, et al. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation. Transplant Proc. 1999;31:2275-2276.
27. Shipkova M, Schutz E, Armstrong VW, et al. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite. Transplant Proc. 1999;31:1135-1137.
28. Beal JL, Jones CE, Taylor PJ, et al. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Ther Drug Monit. 1998;20:685-690.
29. Weber LT, Shipkova M, Armstrong VW, et al. Comparison of the emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Clin Chem. 2002;48:517-525.
30. Shaw LM, Holt DW, Oellerich M, et al. Current issues in therapeutic drug monitoring of mycophenolic acid: a report of a roundtable discussion. Ther Drug Monit. 2001;23:305-315.
31. Armstrong VW, Tenderich G, Shipkova M, et al. Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients. Ther Drug Monit. 2005;27:315-321.